Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

118.75
BATS BZX Real-Time Price
As of 3:42pm ET
 -2.87 / -2.36%
Today’s Change
96.52
Today|||52-Week Range
192.94
-11.70%
Year-to-Date

Today’s Trading

Previous close121.62
Today’s open120.91
Day’s range118.61 - 121.43
Volume13,779
Average volume (3 months)1,182,626
Market cap$6.6B
Dividend yield--
Data as of 3:42pm ET, 09/21/2017

Growth & Valuation

Earnings growth (last year)-27.43%
Earnings growth (this year)-1.29%
Earnings growth (next 5 years)+152.82%
Revenue growth (last year)+14,039.75%
P/E ratioNM
Price/Sales142.97
Price/Book10.67

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc-0.28-0.53%
IONSIonis Pharmaceutical...-2.05-3.80%
ALKSAlkermes Plc-0.13-0.26%
ALNYAlnylam Pharmaceutic...+0.07+0.06%
Data as of 3:42pm ET, 09/21/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.81
Annual revenue (last year)$44.8M
Annual profit (last year)-$387.5M
Net profit margin-864.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Lonnie Moulder
President, Chief Operating Officer &
Director
Mary Lynne Hedley
Corporate headquarters
Waltham, Massachusetts

Forecasts